跳至主要内容
临床试验/CTRI/2025/09/095348
CTRI/2025/09/095348尚未招募2/3 期

A Randomized Open Label Comparative Clinical Study to evaluate the efficacy of Yashtimadhu-Antamula and Bharangi Mool Arka Nebulization in the management of Tamaka Shwasa (Bronchial Asthma) in children

Institute for Ayurved Studies and Research1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年12月1日

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Improvement in the classical signs and symptoms of Tamaka Shwasa such as Shwasa Kashtata, Kasa, Ghurghur Shabda, Peenasa, Asino labhte

研究概览

简要总结

The present clinical study is designed to assess the comparative efficacy of Yashtimadhu–Antamula nebulization and Bharangi Moola Arka nebulization in children of age group 6–18 years of Tamaka Shwasa. A total of 40 patients will be selected from the OPD of the Department of Kaumarbhritya, Institute for Ayurved Studies and Research, SKAU, and randomly allocated into two groups of 20 each. Group A will receive Yashtimadhu–Antamula extract for nebulization and Group B will receive Bharangi Moola Arka nebulization, with 2 ml of the respective medicine administered twice daily for 7 days. The efficacy of treatment will be evaluated on the basis of improvement in classical symptoms of Tamaka Shwasa, along with spirometry and PEFR recordings before and after the intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
6.00 Year(s) 至 18.00 Year(s)(—)
性别
All

入选标准

  • Parents of children willing to participate in the research trial.
  • Children of age group 6-18 years.
  • irrespective of Caste, Sex, Religion and socioeconomic status.
  • The patient having classical sign and symptoms of Tamaka Shwasa.
  • (Bronchial Asthma).

排除标准

  • Any acute or severe illness during treatment.
  • Parents not willing to continue the treatment.
  • Any kind of anaphylactic reaction.

结局指标

主要结局

Improvement in the classical signs and symptoms of Tamaka Shwasa such as Shwasa Kashtata, Kasa, Ghurghur Shabda, Peenasa, Asino labhte

时间窗: 7 days

Saukhayam as well as in PEF and spirometry grading

时间窗: 7 days

次要结局

  • Clinical safety and tolerability of Yashtimadhu-Antamula Nebulization in the management of(Tamaka Shwasa (Bronchial Asthma) will be assessed.)

研究者

发起方
Institute for Ayurved Studies and Research
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Prachi Thind

Institute for Ayurved Studies and Research

研究点 (1)

Loading locations...

相似试验